Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts
Malignant mesothelioma (MM) is a rare disease often associated with environmental exposure to asbestos and other erionite fibers. MM has a long latency period prior to manifestation and a poor prognosis. The survival post-diagnosis is often less than a year. Although use of asbestos has been banned...
Main Authors: | Noushin Nabavi, Jingchao Wei, Dong Lin, Colin C. Collins, Peter W. Gout, Yuzhuo Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2018.00232/full |
Similar Items
-
Well-Differentiated Papillary Mesothelioma of the Peritoneum Is Genetically Distinct from Malignant Mesothelioma
by: Raunak Shrestha, et al.
Published: (2020-06-01) -
Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
by: Yun Gao, et al.
Published: (2022-01-01) -
Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients
by: Roberta Affatato, et al.
Published: (2020-12-01) -
Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma
by: XiaoChang Fang, et al.
Published: (2024-01-01) -
Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations
by: Anita Sejben, et al.
Published: (2023-04-01)